Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in ETON — Eton Pharmaceuticals, Inc.

CIK 1596800 VANCOUVER, A1

Position in ETON

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$476,030
-$577,633 QoQ
Shares Held
13,150
-69.2% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 163 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ETON Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $83,482,045 across 14 Drug Manufacturers - Specialty & Generic names. ETON ranks #10 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ETON

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $476,030 13,150
2026-03-31 $1,053,663 42,693
2025-12-31 $1,295,069 76,586
2025-09-30 $3,125,013 143,811
2025-06-30 $3,164,682 222,083
2025-03-31 $3,018,265 232,532
2024-12-31 $2,862,174 214,878
2024-09-30 $390,084 65,014
2024-06-30 $114,646 34,847
2024-03-31 $147,363 39,297
2023-12-31 $188,681 43,078
2023-09-30 $159,731 38,305